The merger between BerGenBio ASA and Oncoinvent ASA was completed 29 October 2025, and the Combined company was renamed to Oncoinvent. This webpage contains historical documents related to BerGenBio before the merger.

The merger between BerGenBio ASA and Oncoinvent ASA was completed 29 October 2025, and the Combined company was renamed to Oncoinvent. This webpage contains historical documents related to BerGenBio before the merger.
Oncoinvent ASA

Recent News

Oncoinvent ASA: New share capital registered

Read more

Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology

Read more

Oncoinvent ASA: Notification of trade – primary insider/close associate

Read more

Oncoinvent ASA: Resolution to increase the share capital in connection with settlement of underwriting fee

Read more

Oncoinvent ASA: Minutes from Extraordinary General Meeting

Read more

Oncoinvent ASA: Notification of trade – primary insider/close associate

Read more

Oncoinvent ASA: Final results of the rights issue

Read more

Oncoinvent ASA: Preliminary results of the rights issue

Read more

Oncoinvent ASA: Last day of the subscription period in the rights issue

Read more
All news